05:23 PM EDT, 10/01/2024 (MT Newswires) -- Seres Therapeutics ( MCRB ) filed a registration statement on Tuesday for the resale of up to 14.3 million shares by selling stockholder Societe des Produits Nestle from time to time.
Seres won't receive any proceeds from the sale.
Shares of Seres fell 4.6% in recent after-hours activity.
Price: 0.9200, Change: -0.04, Percent Change: -4.63